Analysis of endothelial-to-haematopoietic transition at the single cell level identifies cell cycle regulation as a driver of differentiation
DOI: 10.1186/s13059-020-02058-4
Authors: Giovanni Canu; Emmanouil Athanasiadis; Rodrigo A. Grandy; Jose Garcia-Bernardo; Paulina M. Strzelecka; Ludovic Vallier; Daniel Ortmann; Ana Cvejic
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “E6 medium”. For ECM, use “Vitronectin” at “0.01” “g/l”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| TGFb | 2.0e-6 | g/l |
| FGF | 2.5e-5 | g/l |
Ideally, “PSC” should be obtained at the end of culture.
Step 2: Primitive streak 1
day 1 ~ 2
culture “spheroid” human PSC in “IMDM” for “1” days. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| Ham’s F12 | 25 | % |
| N2 | 1 | % |
| B27 | 0.5 | % |
| BSA | 0.05 | % |
| Ascorbic Acid | 0.001 | mol/l |
| MTG | 4.5e-4 | — |
| Glutamine | 0.002 | mol/l |
| Transferrin | 0.15 | g/l |
| PSA | 1.0e-5 | g/l |
| BMP4 | 1.0e-5 | g/l |
Step 3: Primitive streak 2
day 2 ~ 3
culture “spheroid” human PSC in “IMDM” for “1” days. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| Ham’s F12 | 25 | % |
| N2 | 1 | % |
| B27 | 0.5 | % |
| BSA | 0.05 | % |
| Ascorbic Acid | 0.001 | mol/l |
| MTG | 4.5e-4 | — |
| Glutamine | 0.002 | mol/l |
| Transferrin | 0.15 | g/l |
| PSA | 1.0e-5 | g/l |
| BMP4 | 1.0e-5 | g/l |
| FGF | 5.0e-6 | g/l |
Step 4: mesoderm 1
day 3 ~ 4
culture “spheroid” human PSC in “IMDM” for “1” days. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| Ham’s F12 | 25 | % |
| N2 | 1 | % |
| B27 | 0.5 | % |
| BSA | 0.05 | % |
| Ascorbic Acid | 0.001 | mol/l |
| MTG | 4.5e-4 | — |
| Glutamine | 0.002 | mol/l |
| Transferrin | 0.15 | g/l |
| PSA | 1.0e-5 | g/l |
| BMP4 | 1.0e-5 | g/l |
| FGF | 5.0e-6 | g/l |
| CHIR90021 | 3.0e-6 | mol/l |
Step 5: mesoderm 2
day 4 ~ 6
culture “spheroid” human PSC in “StemPro” for “2” days. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| Ascorbic Acid | 0.001 | mol/l |
| MTG | 4.5e-4 | — |
| Glutamine | 0.002 | mol/l |
| Transferrin | 0.15 | g/l |
| PSA | 1.0e-5 | g/l |
| FGF | 5.0e-6 | g/l |
| VEGF | 1.5e-5 | g/l |
| IL-6 | 1.0e-5 | g/l |
| IL-11 | 5.0e-6 | g/l |
Step 6: endothelial 1
day 6 ~ 9
culture “spheroid” human PSC in “StemPro” for “3” days. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| Ascorbic Acid | 0.001 | mol/l |
| MTG | 4.5e-4 | — |
| Glutamine | 0.002 | mol/l |
| Transferrin | 0.15 | g/l |
| PSA | 1.0e-5 | g/l |
| FGF | 5.0e-6 | g/l |
| VEGF | 1.5e-5 | g/l |
| IL-6 | 1.0e-5 | g/l |
| IL-11 | 5.0e-6 | g/l |
| SCF | 5.0e-5 | g/l |
| IGF1 | 5.0e-6 | g/l |
| EPO | 2000 | U/l |
Ideally, “EC” should express “CDH5”, “PECAM1”, “KDR”, “THY1”, “CD34”, “CD44” at the end of culture.
Step 7: endothelial 2
day 9 ~ 11
culture “adherent” human EC in “StemPro” for “2” days. For ECM, use “Matrigel” at “0.35” “g/m2”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| DMSO | 0.1 | % |
| Nocodazole | 1.0e-4 | g/l |
| PD0332991 | 1.0e-6 | mol/l |
| Roscovitine | 4.0e-6 | mol/l |
| RO3306 | 1.0e-5 | mol/l |
| BMP4 | 1.0e-5 | g/l |
| FGF | 5.0e-6 | g/l |
| VEGF | 5.0e-6 | g/l |
| IL-6 | 1.0e-5 | g/l |
| IL-11 | 5.0e-6 | g/l |
| SCF | 1.0e-4 | g/l |
| IGF1 | 2.5e-5 | g/l |
| TPO | 3.0e-5 | g/l |
| IL-3 | 3.0e-5 | g/l |
| Flt3-L | 1.0e-5 | g/l |
| SHH | 2.0e-5 | g/l |
| angiotensin II | 1.0e-5 | g/l |
| losartan potassium | 1.0e-4 | mol/l |
Ideally, “HPC” should express “RUNX1”, “CDH5”, “CD43”, “CD44” at the end of culture.